Pharyngotomy in head and neck squamous cell carcinoma: functional and oncological aspects

被引:5
|
作者
Remmert, Carolin [1 ]
Mansour, Naglaa [1 ]
Hofauer, Benedikt [1 ]
Scherer, Elias Q. [2 ]
Bas, Murat [1 ]
Bier, Henning [1 ]
Knopf, Andreas [1 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany
[2] Agaples Diakonieklinikum Rotenburg, Dept Otorhinolaryngol Head & Neck Surg, Rotenburg, Wumme, Germany
关键词
Pharyngotomy; head and neck squamous cell carcinoma; outcome; videofluoroscopy; function; QUALITY-OF-LIFE; LATERAL PHARYNGOTOMY; OROPHARYNGEAL CANCER; SURGICAL-TREATMENT; CHEMORADIATION; PRESERVATION; CHEMOTHERAPY; RADIATION; SURVIVAL; SURGERY;
D O I
10.1080/00016489.2017.1355564
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: Head and Neck Surgery constantly has to oppose non-invasive organ preservation methods and therefore should be evaluated especially with regard to clinical and functional outcome. We will discuss the role of pharyngotomy in the treatment of HNSCC. Methods: Seventy-three patients with carcinoma of the oral cavity, oro-/hypopharynx and supraglottis underwent lateral/median pharyngotomy. Functional and oncological parameters were retrospectively assessed and set into clinical context. Results: The 5-year recurrence-free-interval (RFI) was significantly higher with surgery and adjuvant radio(chemo) therapy (80%; mean RFI: 92 months) when compared to conservative treatment (68%; mean RFI: 68 months). The 5-year overall-survival (OS) after surgery and conservative treatment was 71% and 54%, respectively. Compared to other surgical techniques (mean RFI: 82 months), pharyngotomy demonstrated a significant higher 5-year RFI (mean RFI: 89 months). Conclusions: Pharyngotomy achieves good exposure and clear resection margins that result in a notably good oncological outcome with a minimum of functional loss. In particular, among UICC IV oropharyngeal HNSCC, pharyngotomy is superior in OS and RFI to conservative methods.
引用
收藏
页码:1281 / 1287
页数:7
相关论文
共 50 条
  • [31] Pharmacotherapy of head and neck squamous cell carcinoma
    Pan, Quintin
    Gorin, Michael A.
    Teknos, Theodoros N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (14) : 2291 - 2302
  • [32] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Schoppy, David W.
    Sunwoo, John B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (06) : 1033 - +
  • [33] Chemoprevention of squamous cell carcinoma of the head and neck
    Wrangle, John M.
    Khuri, Fadlo R.
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (03) : 180 - 187
  • [34] Functional characterization of chromosomal deletions in head and neck squamous cell carcinoma.
    Farhad, Ramin
    Palop, Vicente Planells
    Tward, Aaron
    CANCER RESEARCH, 2021, 81 (13)
  • [35] Functional characterization of alternatively spliced GSN in head and neck squamous cell carcinoma
    Kelley, Dylan Z.
    Flam, Emily L.
    Guo, Theresa
    Danilova, Ludmila V.
    Zamuner, Fernando T.
    Bohrson, Craig
    Considine, Michael
    Windsor, Eric J.
    Bishop, Justin A.
    Zhang, Chi
    Koch, Wayne M.
    Sidransky, David
    Westra, William H.
    Chung, Christine H.
    Califano, Joseph A.
    Wheelan, Sarah
    Favorov, Alexander V.
    Florea, Liliana
    Fertig, Elana J.
    Gaykalova, Daria A.
    TRANSLATIONAL RESEARCH, 2018, 202 : 109 - 119
  • [36] The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck
    Hamoir, Marc
    Schmitz, Sandra
    Gregoire, Vincent
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (04) : 611 - 624
  • [37] Papillary squamous cell carcinoma versus verrucous squamous cell carcinoma of the head and neck
    Ferlito, A
    Devaney, KO
    Rinaldo, A
    Putzi, MJ
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1999, 108 (03): : 318 - 322
  • [38] SQUAMOUS-CELL CARCINOMA RADIOIMMUNOASSAY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    COOK, DW
    WINEK, T
    BAKER, H
    DEVENEY, CW
    SASAKI, T
    AMERICAN JOURNAL OF SURGERY, 1989, 157 (05): : 503 - 504
  • [39] The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck
    Marc Hamoir
    Sandra Schmitz
    Vincent Gregoire
    Current Treatment Options in Oncology, 2014, 15 : 611 - 624
  • [40] Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes
    Warner, Laura
    O'Hara, James T.
    Lin, Daniel J.
    Oozeer, Nashreen
    Fox, Hannah
    Meikle, David
    Hamilton, David
    Iqbal, Muhammad Shahid
    Robinson, Max
    Paleri, Vinidh
    ORAL ONCOLOGY, 2022, 130